QSI - NASDAQ
Quantum-Si incorporated
$1.28
+3.2%Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
At a Glance
Live Snapshotqsi
Cost of Revenue
Last Annual Value
5.74M
3-Year CAGR
%
5-Year CAGR
%
10-Year CAGR
%
Quantum-Si incorporated Competitors Analysis of Cost of Revenue
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Quantum-Si incorporated NASDAQ:QSI | 5.74M | 113.0% | N/A | N/A | |
 Aura Biosciences, Inc. NASDAQ:AURA | 0.00 | N/A | N/A | N/A | |
 Corvus Pharmaceuticals, Inc. NASDAQ:CRVS | 105.00K | N/A | N/A | N/A | |
 Gossamer Bio, Inc. NASDAQ:GOSS | 1.00M | N/A | N/A | N/A | |
 Inhibrx Biosciences, Inc. NASDAQ:INBX | 2.48M | 27.7% | -1.6% | -17.5% | |
 Lexicon Pharmaceuticals, Inc. NASDAQ:LXRX | 274.00K | -83.3% | -65.4% | -47.2% | |
 Ocugen, Inc. NASDAQ:OCGN | 2.39M | 50.3% | N/A | 3.6% | |
 Verastem, Inc. NASDAQ:VSTM | 5.30M | N/A | N/A | 23.0% | |
 Prothena Corporation plc NASDAQ:PRTA | 3.70M | N/A | N/A | -29.4% | |
 I-Mab NASDAQ:IMAB | 0.00 | N/A | N/A | N/A | |
 Rocket Pharmaceuticals, Inc. NASDAQ:RCKT | 11.03M | N/A | N/A | 51.9% |
Quantum-Si incorporated Fair Value Envelope
Related Guides
Continue your QSI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.